CSTM 2024 Abstract Book - Click Here
Number | Title | Lead Author |
1 | Staphylococcal enterotoxins secreted in platelet concentrates during storage induce platelet activation and heighten Staphylococcus aureus virulence | Sylvia Ighem Chi |
2 | Role of the efflux pump NorB in survival and increased quinolone resistance of Staphylococcus aureus grown in platelet concentrates | Carina Da Silva Paredes |
3 | Impact of Blood Manufacturing Methods on the Biological Age Distribution of Red Blood Cells in Stored Red Cell Concentrates | Sanaz Hemmatibardehshahi |
4 | Exploring the Impact of Gamma Irradiation on Biologically Young and Old Subpopulations of Red Blood Cells | Sanaz Hemmatibardehshahi |
5 | Prolonging the circulatory half-life of C1-esterase inhibitor via albumin fusion | Sangavi Sivananthan |
6 | Cutibacterium acnes contamination of platelet concentrates does not elicit the release and accumulation of proinflammatory factors during storage | Dilini Kumaran |
7 | Identification and Characterization of Small Molecule Drugs that Inhibit Phagocytosis | Melika Loriamini |
8 | Impact of Freezing Method and Number of Freeze Cycles on Plasma in vitro Quality | Roya Pasha |
9 | Can DMSO-free cryosolutions better protect cord blood stem and progenitors from transient warming events (TWE) | Nicolas Pineault |
10 | Comparable bacterial proliferation in red blood cell concentrates stored in DEHT/PAGGSM and DEHP/SAGM containers | Sandra Ramirez- Arcos |
11 | Investigating the quality of blood products from Canadian donors with diabetes | Elyn Rowe |
12 | Impact of changing from PVC-DEHP to PVC-DEHT whole blood collection sets on plasma in vitro quality | Anita Howell |
13 | A comparison of manual vs. automated hematocrit measurement in red blood cell concentrates in PAGGSM additive solution | Geraldine Walsh |
14 | Converting the plasma protein product, clotting factor X, into a novel clot-dissolving agent | Alexandra Witt |
15 | Osmotic Variability in Red Blood Cells from Different Blood Donor Groups | Mahsa Yazdanbakhsh |
16 | Deep machine learning analysis of red blood cell morphological changes during hypothermic storage | Yuanheng Zhao |
17 | Creation of the Canadian Transfusion Trials Group: A Clinical Trials Network for Transfusion Medicine in Canada | Erin Jamula, Jessica Clarke |
18 | Albumin Utilization and Appropriateness: A Prescriber's Perspective | Stephanie Bigsby |
19 | A streamlined approach for the identification of two rare antibodies to high prevalence Cromer antigens: anti-SERF and anti-CRAM | Melanie Bodnar |
20 | Assessment of Rh D-Negative Blood Transfusions in Rh D- Positive Patients | Felicia Deng |
21 | Prevalence of West Nile Virus in Canadian Blood Donors and Assessment of Unconfirmed Positive Screening Rates | Carmen Charlton |
22 | Evaluation of the New Transfusion Medicine Team on a Provincial Level | Brittani Rainkie |
23 | Impact of Therapeutic monoclonal antibodies on timely transfusion of patients | Jacqueline Cote |
24 | Evaluation of the cobas® DPX Duplex Hepatitis A Virus and Parvovirus B19 Nucleic Acid Test (NAT) Assay | Leisa Bruneau |
25 | Donor re-entry following deferral for false reactive human immunodeficiency virus-1/2, hepatitis B virus, hepatitis C virus, syphilis and human T-cell lymphotropic virus-1/2 is effective. | Steven Drews |
26 | Detecting hepatitis A virus in a donor specimen linked to non-fractionated plasma and cellular products: What does it mean? | Steven Drews |
27 | Anti CD 38 Therapy: A 'Dara'ing stepwise approach to serological problem solving | Jennifer Duncan |
28 | Development of A Home Transfusion Program | Alioska Escorcia |
29 | Impact of removal of deferrals for vCJD risk | Mindy Goldman |
30 | 25 Years of changes in donor eligibility criteria: Criteria related to donor age, vital signs, and medical conditions | Mindy Goldman |
31 | 25 years of changes in donor eligibility: criteria related to risk of HIV, HCV and HBV | Mindy Goldman |
32 | Adhering to International Transfusion Standards: A Retrospective Review of a Novel Laboratory Workflow for Detection of the RHCE*CeRN allele. | Kirsten Hannaford |
33 | Characterization of Platelet Donors in the Human Leukocyte Antigen (HLA)/Human Platelet Antigen (HPA) Selected Platelet Program | QingYun (Nancy) Hua |
34 | 1-year of ferritin testing to identify iron deficiency amongst select whole blood donors | Aditi Khandelwal |
35 | Unforeseen Anaphylaxis to Rh Immune Globulin: A Case Report | Marissa Laureano |
36 | Mitigating Alloimmunization after a Massive Fetal-Maternal Hemorrhage: A Case Report | Marissa Laureano |
37 | Optimizing Home Transfusion through Data-Driven Patient Segmentation: Assessing Needs and Resources for High-Priority Patients | Na Li |
38 | Fibrinogen Concentrate vs. Cryoprecipitate in Adult and Pediatric Populations: A Systematic Review of RCT Data | Bonnie Liu |
39 | Effect of Room Temperature Donor Sample Storage Duration on Automated Serologic Blood Group Testing | Johnathan Mack |
40 | Comparison of genotype-predicted and serologically determined red blood cell antigen phenotypes in donors | Johnathan Mack |
41 | Chronic Hepatitis B in Ethnically Diverse Blood Donors | Sheila O'Brien |
42 | COVID-19 vaccination behaviour in blood donors | Sheila O'Brien |
43 | Impact of TRALI mitigation strategies on respiratory failure beyond TRALI | Shuoyan Ning |
44 | Albumin Utilization and Appropriateness: A Provincial Healthcare Quality Improvement Project | Madeline Owens |
45 | Physician Blood Transfusion Orders and Compliance with the Standards: Results of a Single-Centre Audit | Heather Panchuk |
46 | Red Cell Antigen Genotypes and Variants in a National Sample of Blood Donors in Canada | Sheharyar Raza |
47 | Pre-donation blood pressure testing does not help predict risk of vasovagal reactions in apheresis plasma donors | Kaye Romans |
48 | Can A Pop-Up Stop a TACO? A Best Practice Advisory Alert as an Electronic Decision Support Tool to Mitigate the Occurrence of Transfusion Associated Circulatory Overload | Lianne Rotin |
49 | Room-temperature phase change material configuration validation for platelet and plasma protein product transport | Ana Simonette Salaveria |
50 | Confirming the Burden of Non-Reportable Transfusion Reactions to Blood Components - Evaluation of a Sentinel Site Model and Canadian Applicability | Melanie St John |
51 | Pathogen inactivated platelets in pediatrics: a single-centre audit of platelet transfusions | Ingrid Tam |
52 | Is being Greedy actually a bad thing? A review of rule in and rule out criteria for transfusion medicine antibody investigations | Adela Vasilache |
53 | The Clinician's Role: A Rapid Scoping Review of Health System and Policy Implications of Immune Globulin Prescription and Management | Kelly Holloway |
54 | New plasma donors: a qualitative study of retention | Kelly Holloway |
55 | Outreach strategies for a diverse stem cell registry | Kelly Holloway |
56 | Beyond Diagnosis and Treatment: A Qualitative Study of Immune Globulin Recipients' Experiences and Engagement in the Health System | Kelly Holloway |
57 | Relationship of Isohemagglutinin Titres and Reverse Grouping in Renal Transplant Patients | Sebastian Vuong |
58 | Implementing an Electronic Provincial Immune Globulin Utilization Database | Laura Aseltine |
59 | Determining the Impact of Current Canadian Stem Cell Registry Policy on Donor Availability via Dynamic Registry Simulation | John Blake |
60 | Cost Analysis: IVIg Administration in Chronic gMG Patient Populations Across Canada | Maxime Boutin-Caron |
61 | Simulation Modelling to Inform Group O Negative Red Blood Cell Inventory Management | Jasdeep Dhahan |
62 | Vein to Vein… to Vein? Traceability Logistic Challenges in a Novel Organ Donor Transfusion-for-Graft-Rejuvenation Protocol | Luarne Sani |
63 | Nurse-administered SCIg at Infusion Centers is a Viable Alternative to IVIg in Antibody Deficiency | Darshee Ghia |
64 | Scoping review of genomics in clinical care and research: considerations for blood operators | Jennie Haw |
65 | Analysis of participant responses to the 2023 IQMH educational survey on blood regulations: A comprehensive review | Chang Keun Lee |
66 | How to Succeed as a Transfusion Practitioner – Developing the Handbook | Clare O'Reilly |
67 | How an Internal Audit Program Informs Provincial Quality Initiatives in Transfusion Medicine | Joanna McCarthy |
68 | Provincial Transfusion Medicine Program Approach to Preparing Annual Health Canada Report | Joanna McCarthy |
69 | Centralized Screening of IVIg for Central Nervous System Conditions - One Year Post-Implementation | Mandy Feng |
70 | Pediatric Transfusion Camp: Applying Kern's Six-Step Approach to Curriculum Development to create and implement a national pediatric transfusion medicine curriculum | Ines Zuna |